140 related articles for article (PubMed ID: 7557855)
1. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection.
Féray C; Samuel D; Gigou M; Paradis V; David MF; Lemonnier C; Reynès M; Bismuth H
Hepatology; 1995 Oct; 22(4 Pt 1):1084-9. PubMed ID: 7557855
[TBL] [Abstract][Full Text] [Related]
2. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.
Bizollon T; Palazzo U; Ducerf C; Chevallier M; Elliott M; Baulieux J; Pouyet M; Trepo C
Hepatology; 1997 Aug; 26(2):500-4. PubMed ID: 9252166
[TBL] [Abstract][Full Text] [Related]
3. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
[TBL] [Abstract][Full Text] [Related]
4. Pilot study of a short course of ribavirin and alpha interferon in the treatment of chronic active hepatitis C not responding to alpha-interferon alone.
Scotto G; Fazio V; Tantimonaco G
Ital J Gastroenterol; 1996 Dec; 28(9):505-11. PubMed ID: 9131395
[TBL] [Abstract][Full Text] [Related]
5. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy.
Akiyoshi F; Sata M; Uchimura Y; Suzuki H; Tanikawa K
Am J Gastroenterol; 1997 Sep; 92(9):1463-6. PubMed ID: 9317063
[TBL] [Abstract][Full Text] [Related]
6. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
[TBL] [Abstract][Full Text] [Related]
7. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
8. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
9. Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience.
Brillanti S; Miglioli M; Barbara L
J Hepatol; 1995; 23 Suppl 2():13-5; discussion 15-6. PubMed ID: 8720288
[TBL] [Abstract][Full Text] [Related]
10. Patterns of hepatitis C viremia in patients receiving hemodialysis.
Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
[TBL] [Abstract][Full Text] [Related]
12. alpha-Interferon retreatment of patients with chronic hepatitis C.
Rabinovitz M; Block G; Finkelstein SD
Am J Gastroenterol; 1996 Aug; 91(8):1523-6. PubMed ID: 8759654
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation.
Casanovas-Taltavull T; Baliellas C; Benasco C; Serrano TT; Casanova A; Pérez JL; Guerrero L; González MT; Andres E; Gil-Vernet S; Casais LA
Am J Gastroenterol; 2001 Apr; 96(4):1170-7. PubMed ID: 11316166
[TBL] [Abstract][Full Text] [Related]
14. A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation.
Gane EJ; Lo SK; Riordan SM; Portmann BC; Lau JY; Naoumov NV; Williams R
Hepatology; 1998 May; 27(5):1403-7. PubMed ID: 9581698
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes.
Hopf U; Berg T; König V; Küther S; Heuft HG; Lobeck H
J Hepatol; 1996; 24(2 Suppl):67-73. PubMed ID: 8836892
[TBL] [Abstract][Full Text] [Related]
16. Sustained remission and viraemia in chronic hepatitis C treated with recombinant alpha-interferon (rIFN-alpha).
Bresci G; Gambardella L; Parisi G; Banti S; Scatena F; Bertoni M; Capria A
Int J Clin Pharmacol Res; 1995; 15(5-6):175-9. PubMed ID: 8835615
[TBL] [Abstract][Full Text] [Related]
17. Histological and clinical outcome after liver transplantation for hepatitis C.
Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL
Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
[TBL] [Abstract][Full Text] [Related]
18. The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C.
Chemello L; Cavalletto L; Bernardinello E; Guido M; Pontisso P; Alberti A
J Hepatol; 1995; 23 Suppl 2():8-12. PubMed ID: 8720287
[TBL] [Abstract][Full Text] [Related]
19. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level.
Yamada G; Takatani M; Kishi F; Takahashi M; Doi T; Tsuji T; Shin S; Tanno M; Urdea MS; Kolberg JA
Hepatology; 1995 Nov; 22(5):1351-4. PubMed ID: 7590646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
